+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Human Plasma Treated with Ultraviolet and Propiolactone. Six-Year Clinical Evaluation



Human Plasma Treated with Ultraviolet and Propiolactone. Six-Year Clinical Evaluation



JAMA 187: 722-726




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 024803986

Download citation: RISBibTeXText

PMID: 14094292


Related references

Human plasma treated with combined beta-propiolactone and ultraviolet irradiation monitored with Escherichia coli T-3 phage. Fed Proc 21(2): 466, 1962

Beta-Propiolactone Plus Ultraviolet Irradiated Plasma. a Clinical Evaluation for Hepatitis, Toxicity and Allergy. Bibliotheca Haematologica 19: 644-647, 1964

Beta-propiolactone plus ultraviolet irradiated plasma. A clinical evaluation for hepatitis, toxicity and allergy. Proc Congr Int Soc Blood Transfus 9: 644-647, 1962

Clinical evaluation of the hepatitis safety of a beta-propiolactone/ultraviolet treated factor IX concentrate (PPSB). Thrombosis Research 28(1): 75-83, 1982

Betaprone plus ultraviolet treated plasma Six-year clinical evaluation for hepatitis. Jour Amer Med Assoc: 221, 1963

Propiolactone plus ultraviolet-treated plasma without hepatitis. Arch Surg 88(4): 721-724, 1964

The Safety of -Propiolactone as a Biologic Sterilizing Agent: Clinical Evaluation With Human Plasma and Homotransplants. Angiology 12(2): 80-83, 1961

The safety of beta-propiolactone as a biologic sterilizing agent. Clinical evaluation with human plasma and homotransplants. Angiology 12: 80-83, 1961

Inactivation of hepatitis A virus added to pooled human plasma by beta-propiolactone treatment and ultraviolet irradiation. European Journal of Clinical Microbiology 2(4): 355-357, 1983

Evaluation of thrombogenicity of beta-propiolactone/ultraviolet (beta-PL/UV) treated PPSB in chimpanzees. Thrombosis Research 30(3): 235-244, 1983

Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences. Developments in Biological Standardization 67: 311-317, 1987

A Ten year Clinical Study of Plasma Treated with Betaprone and Combined Betaprone Plus Ultraviolet Irradiation. Comparison with Present Methods of Treatment. Pacific Medicine and Surgery 72: 298-302, 1964

A three-year follow-up evaluation on 28 HIV-positive patients treated with ultraviolet B phototherapy. Journal of Investigative Dermatology 104(4): 660, 1995

Hemostatic agents prepared from beta propiolactone uv treated plasma. Haemostasis 15(1): 12, 1985

Long-term tolerance and recovery of beta-propiolactone/ultraviolet (beta PL/UV) treated PPSB in chimpanzees. Thrombosis and Haemostasis 46(2): 511-514, 1981